Veterinary Research Forum
Vet Res Forum

Effect of melatonin loaded chitosan hydrogel on rat spinal cord injury

Document Type : Original Article

Authors

Fariborz Afroozi 1
Ahmad Asghari 1
Gholamreza Abedi 1
Pejman Mortazavi 2
Hesam Uddin Hoseinzadeh 3

1 Department of Veterinary Clinical Sciences, SR.C, Islamic Azad University, Tehran, Iran

2 Department of Veterinary Pathobiology, SR.C, Islamic Azad University, Tehran, Iran

3 Department of Veterinary Clinical Science, Ka.C, Islamic Azad University, Karaj, Iran

https://doi.org/10.30466/vrf.2025.2043413.4497
Abstract
Spinal cord injury (SCI) results in the demise of neural and glial cells, as well as extensive neuro- inflammation. Hydrogel formulation for prolonged release of melatonin (Mel) has demonstrated enhanced effectiveness and safety. In this study, SCI was induced in rats by contusion at the T9 vertebrae. Chitosan (CH) /Mel hydrogel was fabricated and characterized using scanning electron microscopy (SEM) and Fourier transform infra-red to examine its specific effects on the apoptotic and histopathological markers of SCI. The scanning electron microscopy images revealed the presence of porosity in the CH/Mel hydrogel. Forty male Wistar rats were randomly divided into five groups (n = 8), including sham, control (SCI-induced treated locally with 100 µL CH hydrogel), and groups 3, 4, and 5 (treated locally immediately after SCI induction with 100 µL CH hydrogel containing 50.00, 100, and 200 mg kg-1 Mel, respectively). The CH/Mel hydrogel at a dose of 25.00 mg mL-1 significantly increased cell viability in the U87 cell line after 24 hr of exposure. However, at 48 and 72 hr after exposure, Bax and Bcl2 expressions were significantly increased and reduced in the SCI group, respectively, and CH/Mel hydrogel could alleviate their expressions, especially in higher doses. In addition, S100 protein expression was up-regulated in the SCI group. However, CH/Mel hydrogel down-regulated it in a dose-dependent manner. The histopathological findings demonstrated that CH/Mel hydrogel dramatically improved SCI outcomes, like vacuolar degeneration, necrosis, and severe cystic and axonal degenerations. In conclusion, CH/Mel hydrogel induced neuroprotection and it had the potential to be used as a therapeutic agent for the treatment of SCI.

Keywords

Chitosan
Melatonin
Rat
Spinal cord injury

Subjects

1.     Freyermuth-Trujillo X, Segura-Uribe JJ, Salgado-Ceballos H, et al. Inflammation: a target for treatment in spinal cord injury. Cells 2022; 11(17): 2692. doi: 10.3390/cells11172692.
2.     Eli I, Lerner DP, Ghogawala Z. Acute traumatic spinal cord injury. Neurol Clin 2021; 39(2): 471-488.
3.     Hachem LD, Fehlings MG. Pathophysiology of spinal cord injury. Neurosurg Clin N Am 2021; 32(3): 305-313.
4.     Patek M, Stewart M. Spinal cord injury. Anaesth Intensive Care 2020; 21(8): 411-416.
5.     Naseem M, Parvez S. Role of melatonin in traumatic brain injury and spinal cord injury. Sci World J 2014; 2014: 586270. doi: 10.1155/2014/586270.
6.     Cristante AF, Barros Filho TE, Marcon RM, et al. Therapeutic approaches for spinal cord injury. Clinics (Sao Paulo) 2012; 67(10): 1219-1224.
7.     Mao L, Wang H, Qiao L, et al. Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-α and matrix metalloproteinase-9 after spinal cord injury in mice. Mediators Inflamm 2010; 2010: 238321. doi: 10.1155/2010/238321.
8.     Ritz MF, Hausmann ON. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res 2008; 1203: 177-188.
9.     Paterniti I, Genovese T, Crisafulli C, et al. Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma. Naunyn Schmiedebergs Arch Pharmacol 2009; 380(2): 179-192.
10. Wang H, Zhang H, Xie Z, et al. Injectable hydrogels for spinal cord injury repair. Eng Regen 2022; 3(4): 407-419
11. Lin PH, Dong Q, Chew SY. Injectable hydrogels in stroke and spinal cord injury treatment: a review on hydrogel materials, cell-matrix interactions and glial involvement. Mater Adv 2021; 2(1): 2561-2583.
12. Thirupathi K, Raorane CJ, Ramkumar V, et al. Update on chitosan-based hydrogels: preparation, characterization, and its antimicrobial and antibiofilm applications. Gels 2022; 9(1): 35. doi: 10.3390/ gels9010035.
13. Pakulska MM, Ballios BG, Shoichet MS. Injectable hydrogels for central nervous system therapy. Biomed Mater 2012; 7(2): 024101. doi: 10.1088/1748-6041/7/2/024101.
14. Shariatinia Z, Jalali AM. Chitosan-based hydrogels: preparation, properties and applications. Int J Biol Macromol 2018; 115: 194-220.
15. Aranaz I, Alcántara AR, Civera MC, et al. Chitosan: an overview of its properties and applications. Polymers (Basel) 2021; 13(19): 3256. doi: 10.3390/ polym13193256.
16. Ardean C, Davidescu CM, Nemeş NS, et al. Factors influencing the antibacterial activity of chitosan and chitosan modified by functionalization. Int J Mol Sci 2021; 22(14): 7449. doi: 10.3390/ijms22147449.
17. Zhang Y, Zhang WX, Zhang YJ, et al. Melatonin for the treatment of spinal cord injury. Neural Regen Res 2018; 13(10):1685-1692.
18. Xie L, Wu H, Huang X, et al. Melatonin, a natural antioxidant therapy in spinal cord injury. Front Cell Dev Biol 2023; 11: 1218553. doi: 10.3389/ fcell.2023.1218553.
19. Kaczmarek-Szczepańska B, Ostrowska J, Kozłowska J, et al. Evaluation of polymeric matrix loaded with melatonin for wound dressing. Int J Mol Sci 2021;2 2(11): 5658. doi: 10.3390/ijms22115658.
20. Valencia C, Valencia CH, Zuluaga F, et al. Synthesis and application of scaffolds of chitosan-graphene oxide by the freeze-drying method for tissue regeneration. Molecules 2018; 23(10): 2651. doi: 10.3390/ molecules23102651.
21. Gholami M, Gilanpour H, Sadeghinezhad J, et al. Facile fabrication of an erythropoietin-alginate/chitosan hydrogel and evaluation of its local therapeutic effects on spinal cord injury in rats. DARU 2021; 29(2): 255-265.
22. Gül S, Celik SE, Kalayci M, et al. Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats. Surg Neurol 2005; 64(4): 355-361.
23. Cai M, Chen L, Wang T, et al. Hydrogel scaffolds in the treatment of spinal cord injury: a review. Front Neurosci 2023; 17: 1211066. doi: 10.3389/fnins. 2023.1211066.
24. Karsy M, Hawryluk G. Modern medical management of spinal cord injury. Curr Neurol Neurosci Rep 2019; 19(9): 65. doi: 10.1007/s11910-019-0984-1.
25. Ashammakhi N, Kim HJ, Ehsanipour A, et al. Regenerative therapies for spinal cord injury. Tissue Eng Part B Rev 2019; 25(6): 471-491.
26. Wang H, Wang H, Huang H, et al. Melatonin attenuates spinal cord injury in mice by activating the Nrf2/ARE signaling pathway to inhibit the NLRP3 inflammasome. Cells 2022; 11(18): 2809. doi: 10.3390/cells11182809.
27. Li Y, Guo Y, Fan Y, et al. Melatonin enhances autophagy and reduces apoptosis to promote locomotor recovery in spinal cord injury via the PI3K/AKT/mTOR signaling pathway. Neurochem Res 2019; 44(8): 2007-2019.
28. Zhong G, Yang Y, Feng D, et al. Melatonin protects injured spinal cord neurons from apoptosis by inhibiting mitochondrial damage via the SIRT1/Drp1 signaling pathway. Neuroscience 2023; 534: 54-65.
29. Samantaray S, Das A, Thakore NP, et al. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res 2009; 47(2): 134-142.
30. Cayli SR, Kocak A, Yilmaz U, et al. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Eur Spine J 2004; 13(8): 724-732.
31. Hong Y, Palaksha KJ, Park K, et al. Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury. J Pineal Res 2010; 49(3):201-209.
32. Shen Z, Zhou Z, Gao S, et al. Melatonin inhibits neural cell apoptosis and promotes locomotor recovery via activation of the Wnt/β-catenin signaling pathway after spinal cord injury. Neurochem Res 2017; 42(8): 2336-2343.
33. Zhang M, Bai Y, Xu C, et al. Novel optimized drug delivery systems for enhancing spinal cord injury repair in rats. Drug Deliv 2021; 28(1): 2548-2461.
34. Duan K, Liu S, Yi Z, et al. S100-β aggravates spinal cord injury via activation of M1 macrophage phenotype. J Musculoskelet Neuronal Interact 2021; 21(3): 401-412.
35. Lorente L, Martín MM, Abreu-González P, et al. Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury. BMC Neurol 2017; 17(1): 138. doi: 10.1186/s12883-017-0922-2.
36. Esposito E, Genovese T, Caminiti R, et al. Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. J Pineal Res 2008; 45(2): 149-156.
37. Bi J, Shen J, Chen C, et al. Role of melatonin in the dynamics of acute spinal cord injury in rats. J Cell Mol Med 2021; 25(6): 2909-2917.
Veterinary Research Forum
Volume 16, Issue 9
September 2025
Pages 537-543

  • Receive Date 15 October 2024
  • Revise Date 20 January 2025
  • Accept Date 01 February 2025

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us